EUVIMEDEUVIMED entdecken
Crossref

Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants

Jiaren Wang, Lin Zeng, Chang Hong, Hao Cui, Weizhen Wang, Hongbo Zhu, Qimei Li, Yan Li, Ruining Li, Jingzhe He, Hong Zhu, Li Liu iD und 1 weitere

Clinical Endocrinology · 2024

DOI: 10.1111/cen.14990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2024. Verfasst von Jiaren Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Me…. Hauptthemen laut MEDLINE: Cystatin C, Fatty Liver. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects many populations, and screening out the high‐risk populations at an early stage is a challenge. As a sarcopenia index, the relationship between creatinine to cystatin C ratio (CCR) and MASLD remains unclear. This cross‐sectional, prospective study aimed to explore the relationship between CCR and MASLD.

Design

Firstly, explored the correlation between CCR and MASLD in cross‐sectional analyses. Then excluded the population with baseeline diagnosis of MASLD and analyzed the association with baseline CCR levels and the onset of MASLD in the population with available follow‐up data. Univariate and multivariate logistic regression analyses were used to calculate odds ratios (ORs) to evaluate the association between CCR levels and MASLD. Patients and Measurements This study included 368,634 participants from the UK Biobank for cross‐sectional and prospective analyses. The demographic characteristics and laboratory measurements of all participants were obtained from the UK Biobank. MASLD was diagnosed according to the multi‐society consensus nomenclature. Hepatic steatosis was defined as FLI ≥60.

Results

We grouped the study participants according to CCR tertiles. In cross‐sectional analyses, participants in CCR tertile 1 had the highest MASLD risk (OR: 1.070, 95% CI: 1.053−1.088, p < .001). And the similar association was observed in the prospective analyses (CCR tertile 1 OR: 1.340, 95% CI: 1.077−1.660, p = .009; CCR tertile 2 OR: 1.217, 95% CI: 1.021−1.450, p = .029, respectively). After stratification by gender, the significant association between CCR and the onset of MASLD was only observed in males (CCR tertile 1 OR: 1.639, 95% CI: 1.160−2.317, p = .005; CCR tertile 2 OR: 1.322, 95% CI: 1.073−1.628, p = .005, respectively).

Conclusion

Our results indicated that lower CCR was significantly associated with higher risk of MASLD, based on which predictive models can be developed to screen populations at high risk of developing MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystatin CFatty LiverMaleHumansProspective StudiesCreatinineCross-Sectional StudiesBiological Specimen BanksUK Biobank

Stichwörter der Autor:innen

CCRMSFLDUK Biobankrisk factor

Substanzen

CreatinineCystatin C

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Ultrasound, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Medical Oncology, Hengyang Medical School, The First Affiliated Hospital, University of South China, Hengyang, Hunan, China.
  • Nanfang Hospital, Southern Medical University, Guangzhou, China.

ORCID-Profile: Li Liu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangzhou Science and Technology Project
  • Guangdong Province College Students' Innovative Entrepreneurial Training Program

Zitieren

APA

Wang, J., Zeng, L., Hong, C., Cui, H., Wang, W., Zhu, H., Li, Q., Li, Y., Li, R., He, J., Zhu, H., Liu, L., & Xiao, L. (2024). Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants. Clinical Endocrinology. https://doi.org/10.1111/cen.14990

Vancouver

Wang J, Zeng L, Hong C, Cui H, Wang W, Zhu H, et al. Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants. Clinical Endocrinology. 2024. doi:10.1111/cen.14990

BibTeX
@article{Wang2024,
  author = {Wang, Jiaren and Zeng, Lin and Hong, Chang and Cui, Hao and Wang, Weizhen and Zhu, Hongbo and Li, Qimei and Li, Yan and Li, Ruining and He, Jingzhe and Zhu, Hong and Liu, Li and Xiao, Lushan},
  title = {Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants},
  journal = {Clinical Endocrinology},
  year = {2024},
  doi = {10.1111/cen.14990}
}
Kostenlos starten →